Cannata Antonio, Bhatti Prashan, Roy Roman, Al-Agil Mohammad, Daniel Allen, Ferone Emma, Jordan Antonio, Cassimon Barbara, Bradwell Susie, Khawaja Abdullah, Sadler Matthew, Shamsi Aamir, Huntington Josef, Birkinshaw Alexander, Rind Irfan, Rosmini Stefania, Piper Susan, Sado Daniel, Giacca Mauro, Shah Ajay M, McDonagh Theresa, Scott Paul A, Bromage Daniel I
British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine and Sciences, King's College London, London, United Kingdom.
King's College Hospital NHS Foundation Trust, London, United Kingdom.
Front Cardiovasc Med. 2022 Oct 13;9:1037837. doi: 10.3389/fcvm.2022.1037837. eCollection 2022.
Acute myocarditis (AM) is a heterogeneous condition with variable estimates of survival. Contemporary criteria for the diagnosis of clinically suspected AM enable non-invasive assessment, resulting in greater sensitivity and more representative cohorts. We aimed to describe the demographic characteristics and long-term outcomes of patients with AM diagnosed using non-invasive criteria.
A total of 199 patients with cardiac magnetic resonance (CMR)-confirmed AM were included. The majority ( = 130, 65%) were male, and the average age was 39 ± 16 years. Half of the patients were White ( = 99, 52%), with the remainder from Black and Minority Ethnic (BAME) groups. The most common clinical presentation was chest pain ( = 156, 78%), with smaller numbers presenting with breathlessness ( = 25, 13%) and arrhythmias ( = 18, 9%). Patients admitted with breathlessness were sicker and more often required inotropes, steroids, and renal replacement therapy ( < 0.001, < 0.001, and = 0.01, respectively). Over a median follow-up of 53 (IQR 34-76) months, 11 patients (6%) experienced an adverse outcome, defined as a composite of all-cause mortality, resuscitated cardiac arrest, and appropriate implantable cardioverter defibrillator (ICD) therapy. Patients in the arrhythmia group had a worse prognosis, with a nearly sevenfold risk of adverse events [hazard ratio (HR) 6.97; 95% confidence interval (CI) 1.87-26.00, = 0.004]. Sex and ethnicity were not significantly associated with the outcome.
AM is highly heterogeneous with an overall favourable prognosis. Three-quarters of patients with AM present with chest pain, which is associated with a benign prognosis. AM presenting with life-threatening arrhythmias is associated with a higher risk of adverse events.
急性心肌炎(AM)是一种异质性疾病,生存率估计各不相同。临床疑似AM的当代诊断标准能够进行非侵入性评估,从而提高敏感性并获得更具代表性的队列。我们旨在描述使用非侵入性标准诊断的AM患者的人口统计学特征和长期预后。
共纳入199例经心脏磁共振成像(CMR)确诊的AM患者。大多数患者(n = 130,65%)为男性,平均年龄为39±16岁。一半患者为白人(n = 99,52%),其余来自黑人和少数族裔(BAME)群体。最常见的临床表现是胸痛(n = 156,78%),较少患者表现为呼吸困难(n = 25,13%)和心律失常(n = 18,9%)。因呼吸困难入院的患者病情更严重,更常需要使用正性肌力药物、类固醇和肾脏替代治疗(分别为P < 0.001、P < 0.001和P = 0.01)。在中位随访53(IQR 34 - 76)个月期间,11例患者(6%)出现不良结局,定义为全因死亡、心脏骤停复苏和适当的植入式心律转复除颤器(ICD)治疗的综合情况。心律失常组患者的预后较差,不良事件风险几乎高出七倍[风险比(HR)6.97;95%置信区间(CI)1.87 - 26.00,P = 0.004]。性别和种族与结局无显著关联。
AM高度异质性,总体预后良好。四分之三的AM患者表现为胸痛,其预后良好。伴有危及生命心律失常的AM与不良事件风险较高相关。